HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000033 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
71,949
Total Value
$3,399,172.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, CHIEF OPERATING OFFICER | Common Stock | โ | Mar 9, 2026 | Exercise/Conversion | 20,000 | $33.51 | $670,200.00 | 34,366 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Common Stock | โ | Mar 9, 2026 | Sale | 17,900 | $67.75 | $1,212,742.90 | 16,466 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Common Stock | โ | Mar 9, 2026 | Sale | 2,100 | $68.25 | $143,329.20 | 14,366 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Common Stock | โ | Mar 10, 2026 | Exercise/Conversion | 1,546 | $33.51 | $51,806.46 | 15,912 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Common Stock | โ | Mar 10, 2026 | Sale | 8,857 | $67.64 | $599,087.48 | 7,055 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Option to Purchase Common Stock | Derivative | Mar 9, 2026 | Exercise/Conversion | 20,000 | $33.51 | $670,200.00 | 69,224 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Option to Purchase Common Stock | Derivative | Mar 10, 2026 | Exercise/Conversion | 1,546 | $33.51 | $51,806.46 | 67,678 | Direct | โ | View Details |